Showing results (131-140 of 147) with videos related to
Sort By:
Pageof 15
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1995
Intergroup study of fluorouracil plus levamisole as adjuvant therapy for stage II/Dukes' B2 colon cancerC G Moertel, T R Fleming, J S Macdonald, et al.The New England Journal of Medicine|March 14, 1991
Effective surgical adjuvant therapy for high-risk rectal carcinomaJ E Krook, C G Moertel, L L Gunderson, et al.Journal of Surgical Oncology|October 1, 1986
Carcinoids: the prognostic effect of primary site histologic type variationsL A Johnson, P T Lavin, C G Moertel, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1989
Biochemical modulation of fluorouracil: evidence of significant improvement of survival and quality of life in patients with advanced colorectal carcinomaM A Poon, M J O'Connell, C G Moertel, et al.The New England Journal of Medicine|February 8, 1990
Levamisole and fluorouracil for adjuvant therapy of resected colon carcinomaC G Moertel, T R Fleming, J S Macdonald, et al.Journal of Surgical Oncology|December 1, 1986
Gallbladder adenocarcinoma: prognostic significance of tumor acid mucopolysaccharide contentL A Johnson, P T Lavin, Y Y Dayal, et al.JAMA|April 12, 1985
A comparison of three chemotherapeutic regimens in the treatment of advanced pancreatic and gastric carcinoma. Fluorouracil vs fluorouracil and doxorubicin vs fluorouracil, doxorubicin, and mitomycinS A Cullinan, C G Moertel, T R Fleming, et al.Journal of Surgical Oncology|January 1, 1987
Gallbladder adenocarcinoma: the prognostic significance of histologic gradeL A Johnson, P T Lavin, Y Y Dayal, et al.Cancer|March 1, 1983
Carcinoids: the association of histologic growth pattern and survivalL A Johnson, P Lavin, C G Moertel, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 18, 1997
Prospectively randomized North Central Cancer Treatment Group trial of intensive-course fluorouracil combined with the l-isomer of intravenous leucovorin, oral leucovorin, or intravenous leucovorin for the treatment of advanced colorectal cancerR M Goldberg, A K Hatfield, M Kahn, et al.Pageof 15